Citation Impact
Citing Papers
Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study)
2017
Artificial intelligence in healthcare: past, present and future
2017 Standout
Cognitive decline in Parkinson disease
2017
The cerebellum and cognition
2018 Standout
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia
2010
Computer-Aided Diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network
2015
Higher iron in the red nucleus marks Parkinson's dyskinesia
2012
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
2012
Parkinson's disease
2015 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study
2016
Non-motor features of Parkinson disease
2017 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Hyposmia and cognitive impairment in Gaucher disease patients and carriers
2012
Prospective study of plasma urate and risk of Parkinson disease in men and women
2016
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Genetic variability related to serum uric acid concentration and risk of Parkinson's disease
2013
Apomorphine in the treatment of Parkinson's disease: a review
2018
Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S
2013
Works of F. Carrillo being referenced
Low serum uric acid concentration in Parkinson's disease in southern Spain
2012
Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I)
2013
Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain
2009
Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease
2010
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)
2009
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
2013
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease
2009